News

The new location offers room for anticipated growth and establishes a permanent headquarters for the company’s North America Region and US subsidiary, Karl Storz Endoscopy-America. The move is

innovatis will become a fully-integrated part of Roche Applied Science, a global business area of the diagnostic division of Roche. The company will continue to develop and market

pSivida, a drug delivery company, has reported encouraging interim 12-month safety and efficacy results from the first human pharmacokinetic study of Iluvien. The study is being conducted by

Sigma-Aldrich’s expansion of operations in Chile is part of the company’s strategic plan to accelerate growth in Canada, Asia Pacific and Latin America to 25% of corporate sales

In addition, NeoMatrix announced a current oversubscription of the C2 round totaling $1.2 million. In order to accommodate those investors who are part of this $1.2 million oversubscription

Astellas also intends to withdraw a related lawsuit in the Delaware Chancery Court against CV Therapeutics and its directors. Astellas said that it does not see value for

UK-based GW Pharmaceuticals has announced positive preliminary results from a pivotal Phase III double-blind randomized placebo-controlled study of Sativex in patients with spasticity due to multiple sclerosis, who

The Wilms tumor gene (WT1) biomarker is used in the prognosis and follow-up of normal karyotype acute myeloid leukemia (AML) patients, who account for nearly half of AML

Net loss for the 12-month period ended December 31, 2008 was $25.2 million or $1.88 per share, as compared to $13.7 million or $1.09 per share, for the